Abstract

The Memorandum of Understanding provides funds for FY 2011 implementation of the Best Pharmaceuticals for Children Act (BPCA), supporting the scientific research related to pediatric therapeutics. NIDDK will contribute to funding studies conducted under BPCA in approximate proportion to its pediatric research portfolio.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
NIH Intra-Agency Agreements (Y02)
Project #
Y2DK455009-0-0-1
Application #
8342946
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2011
Total Cost
$602,506
Indirect Cost

  Institution

Name
National Institute of Diabetes and Digestive and Kidney Diseases
Department
Type
DUNS #
City
State
Country
Zip Code